Exactly one year ago, we met with panelists at Top 25 Pharma companies, Biogen and GSK, and vendors, PCI Clinical Services and Suvoda, to discuss how adaptations in the clinical supply chain would shape the way clinical operations will function in
the future.
With 2020 behind us, our panelists will reflect on a year’s experience navigating the effects of the pandemic to explore best ways to implement emergent trial designs and trends in supply chain strategy. They will speak about what clinical operations
trends will remain or arise as our society moves beyond the impact of COVID-19.
Questions we will address:
- How have trials designs shifted and supply chain strategies changed to accommodate for an increased need for flexibility and decentralization?
- What evolutions in the clinical supply chain over the past year have become more permanent?
- Looking back, what could have been done differently to increase efficiencies in the supply chain and in managing elements of decentralized trials?
- How have decentralized models evolved from regulatory, operational logistics, distribution, and vendor collaboration standpoints?
This panel discussion will benefit Vice Presidents, Directors, and Managers working in:
- Clinical Operations
- Supply Chain Management
- Drug Supply
- IRT Leads
- Data Management
- Innovation and Technologies
Moderator:
John Ristuccia
SVP, Global Client Services, Suvoda
SVP, Global Client Services, Suvoda
As Senior Vice President, Global Client Services at Suvoda, John provides comprehensive oversight, strategic direction and operational guidance for global services delivery, technical, and support teams. Prior to joining Suvoda, John led professional services teams that consulted with Fortune 2000 companies to structure and negotiate proposals for solutions bringing strategic outcomes that drove sales effectiveness and improved sales operations.
Panelists:
Imran Shakur
Associate Director, Clinical Supply Capabilities, Biogen
Imran Shakur is the Associate Director, Clinical Supply Capabilities at Biogen. He is a seasoned leader and consultant with extensive expertise in SDLC management. Imran oversees IRT and other systems within clinical drug supply at Biogen.
Joseph Bangert
Head of RAMOS IRT, GSK
Joe Bangert joined GSK as a Senior IRT Specialist to configure studies in the RAMOS IRT system and work on strategic programs for the RAMOS team. In 2021, he began a secondment as Head of RAMOS to lead the GSK IRT team and oversee our Study Deployment, QA, Help Desk, and Outsourced IRT Support teams. Prior to GSK, Joe worked at Medidata, Syneos (previously inVentiv Health), and Almac, focusing on EDC and IRT systems for clinical trials from 2003-2019.
Tris Evans
VP, Global Quality, PCI Clinical Services
Tris leads the Clinical Quality teams across PCI. In Tris’ 7 years with PCI, he has been successfully leading and building a well-recognized Global Clinical Quality team, ensuring harmonization of Clinical Quality standards globally. Tris has worked in the pharma industry within various Quality roles for 20 years with experience in commercial, investigational and unlicensed medicine manufacture, release and supply.
Tris is an EU Qualified Person (QP), qualifying in 2011 and is named on PCI commercial and clinical licenses in the UK and Ireland, with experience in multiple product dosage forms.
Scott Dixon
SVP, Strategy, Patient-Centric Solutions, Suvoda
Scott Dixon has spent his entire career in the life sciences technology industry, holding senior leadership positions at companies including ERT, Oracle, Phase Forward, WebMD, and Parexel. As Senior Vice President of Strategy, Patient-Centric Solutions, Scott leads the execution of product strategy with an increasing focus on technology and solutions that supports decentralized and hybrid trials. Prior to this role, Scott acted as Senior Vice President of Product Strategy, overseeing Suvoda’s product roadmap and vision while leading the teams responsible for product management and marketing. Scott is a versatile leader with a proven track record in consistently delivering new product and market strategies for start-ups and Fortune 100 companies in the life sciences and healthcare software application industry.
Andrés Escallón
VP, eClinical Innovation, Suvoda
Andrés is a career eClinical services professional having spent over 15 years in the clinical trial industry. He got his start in 2005 at then PHT Corporation, deploying ePRO and eCOA studies, growing along with the company and eventually joining ERT. There he became a leader in Client Services and eventually was asked to build out and lead their eCOA Clinical Data Management team. Most recently he spent two years working for a small CTMS company called SignalPath, as the Vice President of Digitization. He is a passionate leader who builds strong relationships based on trust and transparency with clients and colleagues alike, leading with integrity and respect.
Abigail Stephens
Manager of Services Delivery, Suvoda
As Manager of Services Delivery at Suvoda, Abigail Stephens oversees the delivery of Interactive Response Technology (IRT/IWRS) for Suvoda’s customers. She is committed to delivering high-quality solutions that enable more efficient management of clinical supplies and patient randomization. She has successfully managed IRT systems for a variety of global pharmaceutical and biotechnology sponsors on a range of indications including oncology, CNS disorders, and rare diseases.
Offering You Peace of Mind to Focus on Your Patients
Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management. Suvoda’s Interactive Response Technology (IRT/IWRS) with Trial Intelligence combines the flexibility of a custom solution with the speed of a configurable platform, offering 4-6 week deployment, reimagined reporting, and easy integration. To learn more, visit www.suvoda.com.